APW
PFE icon

Austin Private Wealth’s Pfizer PFE Stock Holding History

Austin Private Wealth’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,000
Closed -$27 – 279
2024
Q1 		$27 Sell
1,000
-99,000
-99% -$2.75M ﹤0.01% 261
2023
Q4 		$29 Buy
+100,000
New +$3.02M ﹤0.01% 261

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Austin Private Wealth's PFE Position: Q4 2025 in Review

Austin Private Wealth increased its Pfizer (PFE) stake by 1.2% in Q4 2025, buying an estimated $4.67K and bringing the position to 15,636 shares worth $389K. The position accounts for 0.03% of the portfolio, ranked #207.

Austin Private Wealth first reported a position in PFE in Q4 2019 and has held it in 25 quarters since. The position peaked at $837K in Q4 2021. 2,906 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Austin Private Wealth held 15,636 shares of Pfizer worth $389K as of Q4 2025.
  • Austin Private Wealth bought 185 Pfizer shares in Q4 2025, an estimated $4.67K.
  • Pfizer made up 0.03% of Austin Private Wealth's portfolio in Q4 2025, its #207 holding.
  • Austin Private Wealth first reported a position in Pfizer in Q4 2019 and has held it in 25 quarters since.
  • Austin Private Wealth's Pfizer position peaked at $837K in Q4 2021.
  • 2,906 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Austin Private Wealth's 13F filing for Q4 2025, filed 20 Jan 2026.